MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signalingWei Wang, Feng Yang, Tao Shen et al.|Journal of Clinical Investigation|2019Cited by 104
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKTTao Shen, Feng Yang, David D. Moore et al.|Journal of Clinical Investigation|2021Cited by 62
MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockadeWei Wang, Feng Yang|Nature Communications|2022Cited by 46
The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern ChinaLili You, Wei Wang, Xiuwei Zhang et al.|BMC Endocrine Disorders|2023Cited by 3